Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2681 |
|
Actual shortage: | 255 (10%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2417 (90%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
23 (9%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-12-03 | 2020-12-03 | 129512 |
TEVA-DILTIAZEM CD | 180MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2021-02-05 | 2021-03-04 | 133441 |
TEVA-DILTIAZEM XC | 180MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-02-16 | 2023-04-28 | 184919 |
TEVA-DILTIAZEM XC | 180MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-10-12 | 2023-12-07 | 206904 |
TEVA-METHYLPHENIDATE ER-C | 18MG | TABLET (EXTENDED-RELEASE) | Actual shortage | 2017-11-24 | 2020-01-21 | 30668 |
ACT METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2018-11-01 | 2024-02-13 | 65990 |
TEVA-ATOMOXETINE | 18MG | CAPSULE | Resolved | 2020-04-02 | 2021-04-15 | 110670 |
ACT METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2024-03-28 | 2024-05-09 | 223862 |
GEMCITABINE FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2020-02-13 | 1697 |
METHYLPREDNISOLONE SODIUM SUCCINATE FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2017-03-13 | 2021-09-23 | 1714 |
CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2019-06-18 | 2019-07-15 | 86972 |
CEFOXITIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2019-06-27 | 2020-02-07 | 87662 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2019-08-29 | 2020-01-30 | 92663 |
CEFAZOLIN FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2019-09-26 | 2019-10-10 | 94837 |
TEVA-TRYPTOPHAN | 1G | TABLET | Resolved | 2020-02-07 | 2020-03-26 | 105564 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-03-26 | 2020-08-21 | 109595 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-07-23 | 2020-08-21 | 120890 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2020-09-24 | 2020-10-15 | 124995 |
CEFTRIAXONE SODIUM FOR INJECTION | 1G | POWDER FOR SOLUTION | Resolved | 2021-01-07 | 2021-02-12 | 131093 |
TEVA-SUCRALFATE | 1G | TABLET | Resolved | 2021-04-01 | 2021-04-08 | 136759 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63937 | ||
DOCETAXEL INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63940 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64544 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64547 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64550 | ||
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-17 | 2018-10-17 | 64553 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64589 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64592 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64595 | ||
RATIO-MEMANTINE | Discontinued | 2018-10-17 | 2018-10-17 | 64598 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64615 | ||
RATIO-ATORVASTATIN | Discontinued | 2018-10-17 | 2018-10-17 | 64623 |